Fig 1: Histology and levels of optineurin, p62, PSMB5 and LC3 in the retina of viral vector injected rat eyes. A. Representative retinal sections collected following injection of PBS, and GFP-, wild-type OPTN (OPTN)- and E50K-OPTN (E50K)-GFP vectors were stained with hematoxylin and eosin (H & E). GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; and ONL, outer nuclear layer. The retinal ganglion cell number was decreased and the INL thickness was reduced in OPTN- and E50K-injected specimens compared to PBS and GFP controls. Scale bar, 25 μm. B. Retinal sections from rat eyes were stained in parallel with polyclonal anti-optineurin, p62, PSMB5, or LC3 (all in red). An enhanced optineurin (OPTN) and LC3 staining, and a declined PSMB5 and p62 staining were observed in the retinal ganglion layer of OPTN and E50K-injected eyes compared to controls. Scale bar, 25 μm. C. Western blotting for optineurin, PSMB5, LC3, and GAPDH in retinal extracts from GFP-, OPTN-GFP (OPTN)-, and E50K-OPTN-GFP (E50K)-injected eyes. The LC3-I bands were very faint and only those of LC3-II were shown. The level of optineurin overexpression was estimated by comparing the intensities of both (optineurin-GFP + optineurin) bands from optineurin treatment groups to those of the endogenous optineurin band from GFP groups (all were normalized against GAPDH). The optineurin/GAPDH ratios (n = 3) for the GFP, OPTN, and E50K groups were, respectively, 1.0 ± 0.2, 9.5 ± 0.3, and 8.0 ± 0.5. For PSMB5/GAPDH, the corresponding values (relative to the first GFP sample) were 1.1 ± 0.1, 0.5 ± 0.1, and 0.5 ± 0.1; and for LC3/GAPDH, they were 1.0 ± 0.1, 1.6 ± 0.2, and 2.1 ± 0.2. All OPTN and E50K results were significantly (P < 0.0015) different from those of GFP controls.
Fig 2: Alcohol impairs hepatic proteasome function and genetic inhibition of proteasome increases protein levels of hepatic RIP1 and RIP3WT mice were treated with Gao-binge model. A. Total liver lysates were subjected to western blot analysis. B. Densitometry analysis of (A). The levels of PSMA2, PSMC1 and PSMB5 were normalized to the loading control (β-Actin). Values represent means±S.E. (n = 3). C. Twenty micrograms of total liver lysates were used to measure the 20S proteasomal activities using a fluorogenic substrate. Results are presented as means± S.E. (n = 3, *p<0.05 by Student t test). D. Total liver lysates from PSMC1 flox/flox, albumin Cre negative (PSMC1 f/f) and PSMC1 flox/flox, albumin Cre positive (PSMC1 f/f Alb) were subjected to western blot analysis. E. Densitometry analysis of (D). Values represent means±S.E. (n = 3).
Fig 3: Dephosphorylation of RRM2 stimulates RRM2 binding with GSS to promote their corecruitment to the proteasome and subsequent activation of ferroptosis. a, b Reciprocal IP experiments of RRM2 and GSS in RRM2−/− HepG2 cells reconstituted with RRM2WT, RRM2T33A or RRM2T33E. The amount of proteins in the immunoprecipitates was normalized to that in whole-cell lysates (Input), and was graphed in the lower panel. c, d Reciprocal IP experiments for RRM2 and GSS in HepG2 cells with or without NU6102 (20 μM, 24 h) and SB203580 (10 μM, 24 h) treatment. The amount of protein in the immunoprecipitates was normalized to that in whole-cell lysates (Input), and was graphed in the lower panel. e Proximal protein ligation between endogenous GSS and the indicated exogenous RRM2-Myc, as measured by PLA in HepG2 cells expressing RRM2WT, RRM2T33A or RRM2T33E. Scale bar, 20 μm. The PLA signals were also calculated and graphed, and the data from the “Empty” group were arbitrarily set to 1. f RRM2WT, RRM2T33A or RRM2T33E was expressed in reconstituted RRM2−/− HepG2 cells. Immunoprecipitations were acquired with anti-PSMB5 antibodies and further analyzed by immunoblotting using anti-RRM2 and anti-GSS antibodies. GSS and RRM2 enrichment in the immunoprecipitates was calculated as the normalization to the levels in whole-cell lysates (input). g–i GSH (g), cell death (h) and 4-HNE (i) were measured in HepG2 and SMMC-7721 cells with or without RRM2 knockdown before they were further treated with Fer-1 (1 μM, 24 h), ZVAD-FMK (20 μM, 24 h), Nec-1 (20 μM, 24 h), or ectopically expressed GSS, RRM2T33A or RRM2WT in the presence or absence of NU6102 (20 μM, 24 h). The data are shown as the mean ± SD from three biological replicates (including IB). *P < 0.05, **P < 0.01 indicates statistical significance. The data from a–d and f–i were analyzed using one-way ANOVA
Fig 4: Radiation induces the enhancement of proteasomal activity in HC cells(A) Schematic illustration showing how 2D adherent monolayers and 3D spheroid suspensions models were treated with XR at the indicated times. (B) Relative 26S proteasome hydrolysis activity in 2D adherent and 3D spheroid FaDu cells treated with XR/no radiation (NR) as in (A). Data were normalized to the control group (n = 3). (C) Heatmap of transcriptomic analysis results for proteasomal genes in FaDu cells treated with a single fraction of XR (6-Gy) and cultured as normal for 7 days or not as in (A) (n = 3). (D) Images of 2D adherent colony formation assays in FaDu cells expressing vector or exogenous NRF1, PSMB5, PSMD14, or PSMB5 plus PSMD14 treated for 48 h with or without a single 2-Gy dose of XR (n = 3). (E) (Top) Cell survival (%) of 2D colony formation assays related to (D). (Bottom) Relative proteasomal activity in 2D adherent FaDu cells expressing vector or exogenous NRF1, PSMB5, PSMD14, or PSMB5 plus PSMD14 treated for 48 h with a single 2-Gy dose of XR, calculated as the AMC fluorescence increment (fold change) per minute (from the data in Figure S1) and normalized to that of the vector group. (F) Western blot analysis of the levels of NRF1-Myc in FaDu cells treated with or without a single 6-Gy dose for 48 h. (G) Immunofluorescence analysis of localization of exogenous NRF1-Myc in FaDu cells treated with or without a single 6-Gy dose for 48 h. (Top) Representative images. (Bottom) The quantitative analysis: The number of NRF1 foci per cell nucleus. (H) Immunofluorescence analysis of colocalization of exogenous PSMD14-EGFP and endogenous PSMB5 in FaDu cells treated with or without a single 6-Gy dose for 48 h. (Top) Representative images. (Bottom) The quantitative analysis: the number of co-localization foci per cell. (B and E) The statistical data are presented as means ± standard deviation (SD), 1-way ANOVA. (G and H) The statistical analyses of the tail moment of all views from 3 independent experiments, 2-sample t test. ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
Fig 5: Western blot (WB) analysis of immunoproteasome (IP) subunits and alarmins in cardiac tissues of mdx mice at different ages. Representative WB of PSMB5, PSMB8, PSMB9, pERK/total ERK, and p38/total p38 in cardiac tissues of 11 days (11dy), 10 weeks (10w), 9 months (9m), and 18m mdx mice (A). In the lateral panel, densitometric analysis of data, expressed as the ratio of different proteins versus vinculin in arbitrary units. One-way ANOVA with Tukey’s multiple comparisons test: *p < 0.05 (B). Representative WB of receptor for advanced glycation end-products (RAGE), S100β, Foxp3, monocyte chemoattractant protein (MCP)-1, high-mobility group box (HMGB)1, and interleukin (IL)-33 in cardiac tissues of 11dy, 10w, 9m, and 18m mdx mice (C). Data from densitometric analysis are expressed as the ratio of different proteins versus vinculin in arbitrary units in the lateral panel (D). One-way ANOVA with Tukey’s multiple comparisons test: *p < 0.05; **p < 0.01; ***p < 0.001. Each experiment was performed in triplicate wells. All values are expressed as the mean ± SD.
Supplier Page from Abcam for Anti-PSMB5/MB1 antibody